Cencora INC CENCORA INC ORD SHS
Cencora INC CENCORA INC ORD SHS/ US03073E1055 /
0HF3
|
18/11/2024 19:06:31
|
Var.
-
|
Volume |
Denaro06:00:08 |
Lettera06:00:08 |
Capitalizzazione di mercato |
Dividend Y. |
Rapporto P/E |
|
243.20USD
|
-
|
1,931
Fatturato: 466,807.31 |
-Quantità in denaro: - |
-Quantità in lettera: - |
47.86 bill.USD |
0.80% |
28.18 |
Descrizione business
Cencora, formerly known as AmerisourceBergen, is one of the largest global pharmaceutical sourcing and distribution services companies, helping both healthcare providers and pharmaceutical and biotech manufacturers improve patient access to products and enhance patient care. With services ranging from drug distribution and niche premium logistics to reimbursement and pharmaceutical consulting services, Cencora delivers innovative programs and solutions across the pharmaceutical supply channel in human and animal health.
Consiglio di amministrazione & Consiglio di sorveglianza
| CEO |
| Steven H. Collis |
| Consiglio di amministrazione |
| James F. Cleary, Jr., Elizabeth S. Campbell, Gina K. Clark, Kourosh Q. Pirouz, Lazarus Krikorian, Leslie E. Donato, Robert P. Mauch, Silvana Battaglia, Jennifer Dubas |
| Consiglio di sorveglianza |
| Steven H. Collis, D. Mark Durcan, Dennis M. Nally, Henry W. McGee, Kathleen W. Hyle, Lon R. Greenberg, Ornella Barra, Richard W. Gochnauer, Redonda Miller, Lorence H. Kim, M.D. |
Dati aziendali
| Name: |
Cencora Inc |
| Indirizzo: |
1 West First Avenue,Conshohocken, PA 19428-1800, USA |
| Telefono: |
+1-610-727-7000 |
| Fax: |
+1-800-640-5221 |
| E-mail: |
InvestorRelations@cencora.com
|
| Internet: |
https://www.cencora.com/ |
| Industria: |
Healthcare |
| Settore: |
Pharmaceutical Industry |
| Sub settore: |
Pharmaceuticals |
| Fine dell'anno finanziario: |
30/09 |
| Flottante libero: |
55.10% |
| Data dell'IPO: |
04/04/1995 |
